Washburn Theodore James Jr., Principal Accounting Officer at Agios Pharmaceuticals ($AGIO), sold about $532 thousand worth of company shares in five open market transactions over the last year. His most recent sale occurred on March 3, 2026. These sales rank him 6,304th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 5272 | $28.88 | 868.0000 | 74,665,003 | 85.86% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2450 | $0.00 | 2,450.0000 | 74,665,003 | 50.00% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2350 | $0.00 | 0.0000 | 74,665,003 | 100.00% | 0.00% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 8452 | $0.00 | 8,452.0000 | 74,665,003 | 9999.99% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 798 | $28.96 | 6,140.0000 | 74,665,003 | 11.50% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2695 | $0.00 | 6,938.0000 | 74,665,003 | 63.52% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2695 | $0.00 | 5,390.0000 | 74,665,003 | 33.33% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2450 | $0.00 | 4,970.0000 | 74,665,003 | 97.22% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 698 | $28.96 | 2,595.0000 | 74,665,003 | 21.20% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2350 | $0.00 | 3,293.0000 | 74,665,003 | 249.20% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 727 | $28.96 | 4,243.0000 | 74,665,003 | 14.63% | 0.00% |
| Sept. 5, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 8546 | $36.87 | 868.0000 | 74,254,956,000 | 90.78% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 777 | $0.00 | 6,269.0000 | 73,372,696,000 | 14.15% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 231 | $35.54 | 6,038.0000 | 73,372,696,000 | 3.68% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2350 | $0.00 | 8,388.0000 | 73,372,696,000 | 38.92% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 697 | $35.54 | 7,691.0000 | 73,372,696,000 | 8.31% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2450 | $0.00 | 10,141.0000 | 73,372,696,000 | 31.86% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 727 | $35.54 | 9,414.0000 | 73,372,696,000 | 7.17% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 8085 | $0.00 | 8,085.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 6142 | $0.00 | 6,142.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 777 | $0.00 | 0.0000 | 73,372,696,000 | 100.00% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2350 | $0.00 | 2,350.0000 | 73,372,696,000 | 50.00% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2450 | $0.00 | 4,900.0000 | 73,372,696,000 | 33.33% | 0.00% |
| Feb. 5, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 2272 | $34.39 | 5,437.0000 | 73,372,696,000 | 29.47% | 0.00% |
| Feb. 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 6896 | $0.00 | 0.0000 | 73,372,696,000 | 100.00% | 0.00% |
| Feb. 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 6896 | $0.00 | 7,709.0000 | 73,372,696,000 | 848.22% | 0.00% |
| Nov. 8, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 772 | $56.09 | 813.0000 | 73,237,954,000 | 48.71% | 0.00% |
| June 3, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 1362 | $44.39 | 1,524.0000 | 72,967,922,000 | 47.19% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 1913 | $31.75 | 2,886.0000 | 72,161,489,000 | 39.86% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 2350 | $0.00 | 4,700.0000 | 72,161,489,000 | 33.33% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 777 | $0.00 | 777.0000 | 72,161,489,000 | 50.00% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 7350 | $0.00 | 7,350.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 919 | $32.57 | 4,799.0000 | 72,161,489,000 | 16.07% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 2350 | $0.00 | 5,718.0000 | 72,161,489,000 | 69.77% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 295 | $32.57 | 3,368.0000 | 72,161,489,000 | 8.05% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 777 | $0.00 | 3,663.0000 | 72,161,489,000 | 26.92% | 0.00% |
| Feb. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 504 | $26.63 | 2,741.0000 | 72,161,489,000 | 15.53% | 0.00% |
| Feb. 12, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 777 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Feb. 12, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 777 | $0.00 | 3,518.0000 | 72,161,489,000 | 28.35% | 0.00% |
| Feb. 14, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 273 | $25.14 | 3,245.0000 | 72,161,489,000 | 7.76% | 0.00% |
| Aug. 7, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 2918 | $25.39 | 2,741.0000 | 71,256,118 | 51.56% | 0.00% |
| Aug. 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 1232 | $26.26 | 5,659.0000 | 71,256,118 | 17.88% | 0.00% |
| Aug. 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 4150 | $0.00 | 6,891.0000 | 71,256,118 | 151.40% | 0.01% |
| Aug. 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 4150 | $0.00 | 0.0000 | 71,256,118 | 100.00% | 0.01% |
| March 3, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 504 | $24.29 | 2,741.0000 | 71,256,118 | 15.53% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | F | Common stock | 273 | $25.31 | 3,245.0000 | 71,256,118 | 7.76% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 777 | $0.00 | 1,554.0000 | 71,256,118 | 33.33% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 777 | $0.00 | 3,518.0000 | 71,256,118 | 28.35% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 7050 | $0.00 | 7,050.0000 | 71,256,118 | 9999.99% | 0.01% |
| Feb. 16, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 233 | $27.21 | 2,668.0000 | 71,256,118 | 8.03% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 360 | $0.00 | 3,532.0000 | 71,256,118 | 11.35% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 360 | $0.00 | 0.0000 | 71,256,118 | 100.00% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | S | Common stock | 504 | $28.59 | 2,901.0000 | 71,256,118 | 14.80% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | F | Common stock | 127 | $28.91 | 3,405.0000 | 71,256,118 | 3.60% | 0.00% |
| Feb. 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | A | Restricted stock units | 6896 | $0.00 | 6,896.0000 | 71,256,118 | 9999.99% | 0.01% |
| Feb. 10, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Common stock | 777 | $0.00 | 3,445.0000 | 71,256,118 | 29.12% | 0.00% |
| Feb. 10, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | M | Restricted stock units | 777 | $0.00 | 777.0000 | 71,256,118 | 50.00% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Washburn Theodore James Jr. | Principal Accounting Officer | F | Common stock | 273 | $28.44 | 3,172.0000 | 71,256,118 | 7.92% | 0.00% |